RESMED, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 211.1 USD | -3.26% |
|
-4.13% | +22.59% |
ETFs positioned on ResMed, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.09% | 17 M€ | +8.31% | - | |
| 1.03% | 14 M€ | -3.15% | ||
| 0.73% | 204 M€ | +10.54% | ||
| 0.43% | 8 M€ | 0.00% | ||
| 0.43% | 37 M€ | -.--% | ||
| 0.38% | 9 M€ | -.--% | - | |
| 0.38% | 2 M€ | 0.00% | ||
| 0.33% | 104 M€ | +10.52% | ||
| 0.29% | 5 M€ | -72.95% | - | |
| 0.21% | 50 M€ | +11.38% | ||
| 0.20% | 9 M€ | +10.39% | ||
| 0.20% | 253 M€ | +6.95% | ||
| 0.18% | 219 M€ | +17.17% | - | |
| 0.18% | 1,448 M€ | -.--% | - | |
| 0.18% | 2,383 M€ | +14.57% | ||
| 0.16% | 8 M€ | +7.53% | - | |
| 0.16% | 744 M€ | +10.58% | ||
| 0.16% | 36 M€ | +22.19% | ||
| 0.16% | 4 M€ | -.--% | - | |
| 0.13% | 85 M€ | +13.18% | - | |
| 0.13% | 276 M€ | +11.40% | - | |
| 0.12% | 264 M€ | -.--% | - | |
| 0.12% | 187 M€ | +11.14% | - | |
| 0.12% | 477 M€ | +12.74% | ||
| 0.11% | 7 M€ | +6.17% | - | |
| 0.11% | 32 M€ | +1.48% | - | |
| 0.11% | 17 M€ | +4.93% | - |
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
2024-07-31
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
218.3
USD
Average target price
216.6
USD
Spread / Average Target
-0.74%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.59% | 32.07B | |
| +10.21% | 226B | |
| +13.66% | 198B | |
| +17.62% | 142B | |
| +28.89% | 111B | |
| +2.09% | 65.26B | |
| +14.43% | 54.36B | |
| +6.68% | 50.94B | |
| +8.02% | 44.8B | |
| +3.13% | 36.8B |
- Stock Market
- Equities
- RMD Stock
- Funds and ETFs ResMed, Inc.
